Shanghai HeartCare Medical Technology (HKSE:06609) EBIT per Share : HK$-2.90 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Shanghai HeartCare Medical Technology EBIT per Share?

Shanghai HeartCare Medical Technology's EBIT per Share for the six months ended in Dec. 2023 was HK$-1.36. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-2.90.

During the past 3 years, the average EBIT per Share Growth Rate was 22.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Shanghai HeartCare Medical Technology's EBIT per Share or its related term are showing as below:

HKSE:06609' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -35.6 Med: -6.65 Max: 22.3
Current: 22.3

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Shanghai HeartCare Medical Technology was 22.30% per year. The lowest was -35.60% per year. And the median was -6.65% per year.

HKSE:06609's 3-Year EBIT Growth Rate is ranked better than
72% of 725 companies
in the Medical Devices & Instruments industry
Industry Median: 5.7 vs HKSE:06609: 22.30

Shanghai HeartCare Medical Technology's EBIT for the six months ended in Dec. 2023 was HK$-51.7 Mil.

Shanghai HeartCare Medical Technology EBIT per Share Historical Data

The historical data trend for Shanghai HeartCare Medical Technology's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai HeartCare Medical Technology EBIT per Share Chart

Shanghai HeartCare Medical Technology Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

-2.16

-6.55

-7.17

-5.81

-2.89

Shanghai HeartCare Medical Technology Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT per Share	Get a 7-Day Free Trial				-3.78	-2.03	-3.87	-1.54	-1.36

Shanghai HeartCare Medical Technology EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Shanghai HeartCare Medical Technology's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-110.211	/	38.077
=	-2.89

Shanghai HeartCare Medical Technology's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-51.683	/	38.014
=	-1.36

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-2.90

Shanghai HeartCare Medical Technology (HKSE:06609) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Shanghai HeartCare Medical Technology EBIT per Share Related Terms

Thank you for viewing the detailed overview of Shanghai HeartCare Medical Technology's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai HeartCare Medical Technology (HKSE:06609) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai HeartCare Medical Technology Corp Ltd (HKSE:06609) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 356, Zhengbo Road, Floor 1 and 3, Building 38, Pilot Free Trade Zone, Lingang New District, Shanghai, CHN

Website

http://www.strokemedical.com

Shanghai HeartCare Medical Technology Corp Ltd is an innovative neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. Geographically, the Group's revenue is derived from Mainland China.

Executives

Ding Kui	2201 Interest of corporation controlled by you
Wisary Limited	2101 Beneficial owner
Wang Guohui
Shanghai Zandaqian Enterprise Management Consulting Center
Lyfe Capital Management Limited
Lyfe Capital Fund Iii (dragon), L.p.
Shanghai Weiyun Enterprise Management Consulting Partnership (lp)
Lyfe Columbia River Limited
Temasek Holdings (private) Limited
Elbrus Investments Pte. Ltd.
Fullerton Management Pte Ltd
Temasek Life Sciences Private Limited

Shanghai HeartCare Medical Technology (HKSE:06609) Headlines

No Headlines